Join Our Clinical Research Study 

Help Advance Treatment for Atopic Dermatitis (Eczema) 

Phase I Clinical Trial Now Enrolling 

About the study:

We are conducting a Phase I clinical research study to evaluate the safety and tolerability of an investigational treatment for atopic dermatitis (eczema). This first-in-human study will help determine if this new therapy could potentially benefit people living with moderate-to-severe atopic dermatitis. 

You may qualify if you:

  • Are 18-70 years of age

  • Have been diagnosed with atopic dermatitis for at least 12 months 

  • Have moderate to severe atopic dermatitis affecting ≥10% body surface area 

  • Have had inadequate response to topical treatments, such as steroids 

  • Are in general good health aside from atopic dermatitis 

  • Are not pregnant or planning to become pregnant 

  • Can commit to all study visits and procedures 

Study duration:

Approximately 52 weeks including the follow-up period.

Number of Visits: 10-20 clinic visits 

What’s involved?

If you qualify and choose to participate, you will: 

  • Receive study medication at no cost 

  • Have regular health monitoring and skin assessments 

  • Undergo blood tests and other safety evaluations 

  • Complete quality of life questionnaires 

Qualified participants will receive compensation for time and travel. 

Enquire for more information

Interested in learning more? 

Contact our research team today for a confidential screening. 

[email protected]| +64 4 8050243

This study has been reviewed and approved by the Northern A Health and Disability Ethics Committee, Ref# 2026 FULL 24259.

Participation is entirely voluntary, and you may withdraw at any time without affecting your regular medical care. Your privacy and confidentiality will be protected throughout the study.